BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22545010)

  • 1. Investigation of dose minimisation protocol for 18F-FDG PET-CT in the management of lymphoma postchemotherapy followup.
    Sonoda LI; Sanghera B; Wong WL
    ScientificWorldJournal; 2012; 2012():208135. PubMed ID: 22545010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
    Kong G; Jackson C; Koh DM; Lewington V; Sharma B; Brown G; Cunningham D; Cook GJ
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1323-9. PubMed ID: 18347794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR; McConathy J; Laforest R; Khanna G
    Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
    Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
    Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
    Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
    AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö; Baran Y; Oral A; Ceylan Y
    Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
    Qi Z; Gates EL; O'Brien MM; Trout AT
    Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
    Westwood TD; Hogan C; Julyan PJ; Coutts G; Bonington S; Carrington B; Taylor B; Khoo S; Bonington A
    Eur J Radiol; 2013 Aug; 82(8):e374-9. PubMed ID: 23578921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
    Tirumani SH; LaCasce AS; Jacene HA
    PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.
    Schäfer JF; Gatidis S; Schmidt H; Gückel B; Bezrukov I; Pfannenberg CA; Reimold M; Ebinger M; Fuchs J; Claussen CD; Schwenzer NF
    Radiology; 2014 Oct; 273(1):220-31. PubMed ID: 24877983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
    Mena E; Lindenberg ML; Turkbey BI; Shih J; Logan J; Adler S; Wong K; Wilson W; Choyke PL; Kurdziel KA
    Clin Nucl Med; 2014 Oct; 39(10):874-81. PubMed ID: 25144214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.